基于RNA的新型疗法用于治疗失脂症
Constantine E Kosmas1, Maria D Bousvarou2, Donatos Tsamoulis1
12nd Department of Cardiology, National & Kapodistrian University of Athens, 12462 Athens, Greece.
International journal of molecular sciences
|February 13, 2025
概括
新型基于RNA的疗法,包括反感性寡核酸和小干扰RNA,通过向特定的基因来治疗脱脂症有望出现. 这些创新治疗方法在脂质管理和心血管风险降低方面提供了潜在的改善.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 脂质失调症,以脂质平衡异常为特征,是一种慢性疾病.
- 制药技术的进步导致了慢性疾病的创新疗法.
- 核酸疗法通过向mRNA提供了新的管理策略.
研究的目的:
- 讨论完成和正在进行的RNA治疗失脂症的试验中的最新数据.
- 突出基于RNA的疗法在治疗失脂症和动脉样硬化心血管疾病方面的潜力.
- 探索基于RNA的新型药物在有效的脂质管理中的作用.
主要方法:
- 利用反感性寡核酸 (ASOs) 和小干扰RNA (siRNAs) 来使特定的基因沉默.
- 向mRNA以抑制蛋白质生产 (ASOs) 或诱导降解 (siRNAs).
- 审查RNA治疗的临床试验数据,如inclisiran,pelacarsen和其他针对PCSK9,Lp(a),ApoC-III和ANGPTL3.3的药物.
主要成果:
- 基于RNA的疗法对脂质参数产生显著影响.
- 化学修饰增强了这些疗法的稳定性和mRNA向性.
- 目前正在进行的试验的有希望的结果表明,改善脂质治疗的潜力.
结论:
- 针对PCSK9,Lp(a),ApoC-III和ANGPTL3的基于RNA的疗法具有变革性的潜力.
- 这些新型药物对有效的失脂症管理和心血管风险降低有前途.
- 预计进一步的研究将完善RNA基剂在临床实践中的作用.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
517
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
517
siRNA - Small Interfering RNAs
16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Types of RNA
63.1K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.1K
RNA Editing
8.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K


